Edition:
United States

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

3.51USD
18 Jun 2018
Change (% chg)

-- (--)
Prev Close
$3.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
291,638
52-wk High
$6.66
52-wk Low
$3.33

Chart for

About

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address unmet medical needs. The Company is focused on developing products in immuno-oncology that employ gene expression, control and cell technologies... (more)

Overall

Beta: 1.60
Market Cap(Mil.): $612.32
Shares Outstanding(Mil.): 142.40
Dividend: --
Yield (%): --

Financials

  ZIOP.OQ Industry Sector
P/E (TTM): -- 240.92 34.18
EPS (TTM): -0.54 -- --
ROI: -71.04 -5.87 13.17
ROE: -- -7.71 15.15

BRIEF-Ziopharm Oncology Reports Q1 Loss Per Share $0.15

* ZIOPHARM ONCOLOGY REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 10 2018

BRIEF-Ziopharm Oncology Addresses Rumors And Stock Volatility, Affirms 2018 Guidance

* ZIOPHARM ONCOLOGY ADDRESSES RUMORS AND STOCK VOLATILITY, AFFIRMS 2018 GUIDANCE

Feb 06 2018

BRIEF-Ziopharm Oncology To Initiate Pivotal Trial Of Cancer Treatment in Second Half of 2018

* ZIOPHARM ONCOLOGY PROVIDES UPDATE ON STANDOUT TECHNOLOGIES DURING THE 36TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Jan 09 2018

Earnings vs. Estimates